Compass Ion Advisors’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Other funds holding GMED
Compass Ion Advisors's GMED Position: Q3 2026 in Review
Compass Ion Advisors held its Globus Medical (GMED) position steady in Q3 2026 at 28,406 shares worth $2.13M. The position accounts for 0.18% of the portfolio, ranked #69.
Compass Ion Advisors first reported a position in GMED in Q4 2019 and has held it in 25 quarters since. The position peaked at $3.59M in Q4 2021. 614 funds tracked by Wall St. Rank hold GMED as of Q3 2026.
- Compass Ion Advisors held 28,406 shares of Globus Medical worth $2.13M as of Q3 2026.
- Compass Ion Advisors left its Globus Medical share count unchanged in Q3 2026.
- Globus Medical made up 0.18% of Compass Ion Advisors's portfolio in Q3 2026, its #69 holding.
- Compass Ion Advisors first reported a position in Globus Medical in Q4 2019 and has held it in 25 quarters since.
- Compass Ion Advisors's Globus Medical position peaked at $3.59M in Q4 2021.
- 614 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.
Based on Compass Ion Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.